Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/pretiorates-thoughts-72-how-sharp-are-the-bears-claws/